Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IONS |
---|---|---|
09:32 ET | 87414 | 38.795 |
09:34 ET | 144325 | 38.35 |
09:36 ET | 24820 | 38.095 |
09:38 ET | 57777 | 38.03 |
09:39 ET | 8620 | 38.52 |
09:41 ET | 14888 | 38.165 |
09:43 ET | 2210 | 38.11 |
09:45 ET | 203316 | 38.22 |
09:48 ET | 15494 | 38.39 |
09:50 ET | 728 | 38.33 |
09:52 ET | 3298 | 37.92 |
09:54 ET | 9295 | 37.72 |
09:56 ET | 6334 | 37.97 |
09:57 ET | 500 | 37.955 |
09:59 ET | 6093 | 37.965 |
10:01 ET | 7902 | 37.88 |
10:03 ET | 7066 | 37.91 |
10:06 ET | 2881 | 37.86 |
10:08 ET | 31336 | 37.655 |
10:10 ET | 20399 | 37.59 |
10:12 ET | 3435 | 37.6 |
10:14 ET | 367944 | 37.625 |
10:15 ET | 1400 | 37.68 |
10:17 ET | 1100 | 37.65 |
10:19 ET | 15322 | 37.49 |
10:21 ET | 2028 | 37.56 |
10:24 ET | 4076 | 37.575 |
10:26 ET | 5163 | 37.52 |
10:28 ET | 2531 | 37.55 |
10:30 ET | 2718 | 37.49 |
10:32 ET | 3098 | 37.5 |
10:33 ET | 3040 | 37.48 |
10:35 ET | 11113 | 37.28 |
10:37 ET | 18391 | 37.27 |
10:39 ET | 33241 | 37.135 |
10:42 ET | 15285 | 36.94 |
10:44 ET | 8076 | 36.9 |
10:46 ET | 15621 | 36.87 |
10:48 ET | 32729 | 36.82 |
10:50 ET | 7529 | 36.845 |
10:51 ET | 7500 | 37.1824 |
10:53 ET | 4850 | 37.03 |
10:55 ET | 5243 | 36.9815 |
10:57 ET | 3719 | 37.04 |
11:00 ET | 5929 | 37.135 |
11:02 ET | 1625 | 37.1441 |
11:04 ET | 4823 | 37.035 |
11:06 ET | 2500 | 37.3 |
11:08 ET | 2025 | 37.29 |
11:09 ET | 4084 | 37.17 |
11:11 ET | 6979 | 37.23 |
11:13 ET | 2932 | 37.34 |
11:15 ET | 2361 | 37.3348 |
11:18 ET | 1396 | 37.34 |
11:20 ET | 5031 | 37.3 |
11:22 ET | 1020 | 37.315 |
11:24 ET | 5271 | 37.26 |
11:26 ET | 3774 | 37.22 |
11:27 ET | 2161 | 37.2347 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ionis Pharmaceuticals Inc | 5.7B | -13.9x | --- |
Halozyme Therapeutics Inc | 5.8B | 18.9x | --- |
Apellis Pharmaceuticals Inc | 5.1B | -11.9x | --- |
Intra-Cellular Therapies Inc | 7.1B | -57.9x | --- |
CRISPR Therapeutics AG | 4.8B | -20.6x | --- |
ACADIA Pharmaceuticals Inc | 2.5B | -1,157.0x | --- |
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.7B |
---|---|
Revenue (TTM) | $776.6M |
Shares Outstanding | 146.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.35 |
EPS | $-2.67 |
Book Value | $2.68 |
P/E Ratio | -13.9x |
Price/Sales (TTM) | 7.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -45.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.